SOPHiA GENETICS to Participate in Upcoming November Investor Conferences
10/28/2021 - 04:05 PM
BOSTON and LAUSANNE, Switzerland, Oct. 28, 2021 (GLOBE NEWSWIRE) -- SOPHiA GENETICS SA (Nasdaq: SOPH) today announced the company will be participating virtually in the following investor conferences:
Credit Suisse 30th Annual Healthcare Conference; Fireside Chat on Thursday, November 11th at 2:40pm ET / 8:40pm CET Piper Sandler 33rd Annual Healthcare Conference; Presentation available on demand beginning November 22nd at 10:00am ET / 4:00pm CET Evercore ISI HealthCONx Conference; Fireside Chat on Tuesday, November 30th at 8:00am ET / 2:00pm CET Interested parties may access live and archived webcasts of the presentations on the “Investors” section of the company website at ir.sophiagenetics.com.
About SOPHiA GENETICS SOPHiA GENETICS (Nasdaq: SOPH) is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It is the creator of the SOPHiA DDM™ Platform, a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The SOPHiA DDM™ Platform and related solutions, products and services are currently used by more than 780 hospital, laboratory, and biopharma institutions globally.
Media Contact: Eliza Bamontiebamonti@sophiagenetics.com
Investor Contact: ir@sophiagenetics.com
SOPH Rankings
#276 Ranked by Stock Gains
SOPH Stock Data
Industry
Biological Product (except Diagnostic) Manufacturing
Sector
Manufacturing
About SOPH
sophia genetics, world's largest clinical genomics community, brings together expertise in genetics, bioinformatics, machine learning and genomic privacy. based in switzerland, we are known for our high medical standards and swiss precision. sophia genetics offers health professionals who perform clinical genetic testing unparalleled bioinformatics analysis, quality assurance and secure banking of patient dna sequence data generated by ngs. the company helps clinical laboratories to reduce costs, overcome complexity, significantly improve the turnaround time for routine diagnosis and meet quality requirements related to the use of ngs in the clinic. our solution, the sophia ddm™ platform allows hospitals to better and faster diagnose patients using cutting edge ngs analytics algorithms and through knowledge sharing within the largest clinical genomics community in the world (+100 hospitals). the name « sophia » means wisdom in greek and it is the definition of our excellence based